biotech news today obesity drugs glp-1 Novartis, Alector, Merck, Alnylm, UniQure : Readout Newsletter With China approval, Lilly and

How much weight can I expect to lose with GLP-1 agonists

More than half (55 people) of people with a BMI below 25 report their main motivation for using a weight loss drug is to improve body confidence or self-esteem and around half (52 percent) of this cohort say that celebrity endorsement made them more open to trying the medication." "When prescribed by a registered doctor or a licensed prescribing pharmacist, with appropriate support in place, these medicines can be highly effective for some patients

(2021) Tirzepatide versus semaglutide once weekly in patients with type 2 diabetes

doi: 10.1007/s11883-022-01062-2 [DOI] [PubMed] [Google Scholar] 144

A small percentage of patients may find that Semaglutide produces only a mild reduction in appetite, even after reaching the highest therapeutic doses